Table 3.
Alleles in Caucasian with adjusted P value less than 0.05 and occurred in 2 or more tumors
| Allele | Count in Tumor Samples | Prevalence in Patient Series (%) | Prevalence in NMDP (%) | Prevalence Ratio | P value | Adjusted P value |
|---|---|---|---|---|---|---|
| Caucasian - All tumors | ||||||
| C*08:02 | 22 | 7.48 | 3.85 | 1.94 | 0.003 | 0.047 |
| B*14:02 | 21 | 7.14 | 2.86 | 2.50 | 0.000 | 0.003 |
| B*44:02 | 10 | 3.40 | 9.52 | 0.36 | 0.000 | 0.003 |
| A*03:02 | 5 | 1.70 | 0.24 | 7.09 | 0.001 | 0.014 |
| B*44:06 | 2 | 0.68 | 0.00 | 170 | 0.000 | 0.003 |
| Caucasian - Breast cancer | ||||||
| C*08:02 | 5 | 17.8 | 3.85 | 4.64 | 0.004 | 0.022 |
| B*14:02 | 4 | 14.3 | 2.86 | 5.00 | 0.008 | 0.034 |
| B*44:06 | 2 | 7.14 | <.01 | >100 | <.001 | <.001 |
| B*47:01 | 2 | 7.14 | 0.27 | 26.5 | 0.003 | 0.022 |
| Caucasian - CNS malignancy | ||||||
| B*49:01 | 2 | 25.0 | 1.58 | 15.8 | 0.007 | 0.033 |
| Caucasian - GI cancer | ||||||
| C*15:05 | 3 | 4.17 | 0.35 | 11.9 | 0.002 | 0.044 |
| A*02:02 | 2 | 2.78 | 0.09 | 30.9 | 0.002 | 0.044 |
| Caucasian - H&N cancer | ||||||
| A*02:01 | 5 | 83.3 | 27.6 | 3.02 | 0.007 | 0.015 |
| B*50:01 | 2 | 33.3 | 1.05 | 31.8 | 0.002 | 0.006 |
| Caucasian - Pancreatobiliary cancer | ||||||
| A*68:02 | 3 | 7.14 | 0.84 | 8.50 | 0.005 | 0.031 |
| B*58:01 | 3 | 7.14 | 0.73 | 9.78 | 0.004 | 0.031 |
| C*03:02 | 3 | 7.14 | 0.22 | 32.5 | 0.000 | 0.003 |
| A*03:02 | 2 | 4.76 | 0.24 | 19.8 | 0.005 | 0.031 |
| A*69:01 | 2 | 4.76 | 0.14 | 34.0 | 0.002 | 0.024 |
| Caucasian - Sarcoma | ||||||
| A*03:02 | 2 | 25.0 | 0.24 | 104 | 0.000 | 0.001 |
| Black or African American - Pancreatobiliary cancer | ||||||
| C*16:01 | 2 | 50.0 | 9.69 | 5.16 | 0.049 | 0.049 |
| Hispanic - Breast adenocarcinoma | ||||||
| A*02:01 | 2 | 100 | 20.9 | 4.77 | 0.044 | 0.044 |
| Hispanic - GI cancer | ||||||
| C*12:03 | 2 | 33.3 | 4.15 | 8.03 | 0.023 | 0.046 |